| Item | Value |
|---|---|
| DrugBank ID | DB00571 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 28 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | placental hemangioma | TxGNN Knowledge Graph |
| 2 | multifocal atrial tachycardia (disease) | TxGNN Knowledge Graph |
| 3 | composite hemangioendothelioma | TxGNN Knowledge Graph |
| 4 | Kasabach-Merritt syndrome | TxGNN Knowledge Graph |
| 5 | epithelioid hemangioendothelioma | TxGNN Knowledge Graph |
| 6 | retinal capillary malformation | TxGNN Knowledge Graph |
| 7 | laryngotracheal angioma | TxGNN Knowledge Graph |
| 8 | congenital hemangioma | TxGNN Knowledge Graph |
| 9 | hypertrophic cardiomyopathy | TxGNN Knowledge Graph |
| 10 | hemangioma | TxGNN Knowledge Graph |
| 11 | primary intraosseous venous malformation | TxGNN Knowledge Graph |
| 12 | retiform hemangioendothelioma | TxGNN Knowledge Graph |
| 13 | lymphangioma | TxGNN Knowledge Graph |
| 14 | glomus tumor | TxGNN Knowledge Graph |
| 15 | cavernous hemangioma | TxGNN Knowledge Graph |
| 16 | verrucous hemangioma | TxGNN Knowledge Graph |
| 17 | His bundle tachycardia | TxGNN Knowledge Graph |
| 18 | cavernous hemangiomas of face-supraumbilical midline raphe syndrome | TxGNN Knowledge Graph |
| 19 | kaposiform hemangioendothelioma | TxGNN Knowledge Graph |
| 20 | pulmonary venoocclusive disease | TxGNN Knowledge Graph |
| 21 | familial hypertrophic cardiomyopathy | TxGNN Knowledge Graph |
| 22 | primary intralymphatic angioendothelioma | TxGNN Knowledge Graph |
| 23 | hypertension | TxGNN Knowledge Graph |
| 24 | atrial fibrillation (disease) | TxGNN Knowledge Graph |
| 25 | hypertensive disorder | TxGNN Knowledge Graph |
| 26 | spindle cell hemangioma | TxGNN Knowledge Graph |
| 27 | hereditary neurocutaneous angioma | TxGNN Knowledge Graph |
| 28 | tufted angioma (disease) | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.